Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related policy notices, general notices, notices of change, notices of special interest NOSI, and funding opportunities:
Policy Notices
- Notice of Update to the Reporting Period of the Annual Report to OLAW
National Institutes of Health
- Reissue of Parent Announcements (PA-18-589, PA-18-590, PA-18-591, and PA-18-592) and the Urgent (PA-18-935) and Emergency (PA-20-135) Competitive Revision FOAs is Underway - Continue to use the Current Announcements and Forms Packages Until Reissuance
National Institutes of Health
General Notices
- NICHD Late Application Policy for Institutional Training Grants to RFA-HD-21-014 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NHLBI Announces Availability of Frequently Asked Questions (FAQs) for PAR-19-329 and PAR-19-330: Multi-Site Investigator-Initiated Clinical Trials
National Heart, Lung, and Blood Institute
- Request for Information: Use of Cloud Resources and New File Formats for Sequence Read Archive Data
National Institutes f Health
- Request for Information (RFI): Input on Improvements to the Illuminating the Druggable Genome (IDG) Programs Digital Resources
Office of Strategic Coordination (Common Fund)
Notice of Changes to Funding Opportunities
- Notice of Early Expiration of Notice of Special Interest (NOSI): Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)," NOT-AI-20-031
National Institute of Allergy and Infectious Diseases
- Notice of Clarification to Eligibility Information in RFA-AI-20-023 Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Notice of NIDCD's Withdrawal from Participation in PA-20-183 "Research Project Grant (Parent R01 Clinical Trial Required)"
National Institute on Deafness and Other Communication Disorders
- Notice of Change in Application Due Date for PAR-19-215 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)
National Institute of Biomedical Imaging and Bioengineering
- NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July
National Human Genome Research Institute
Notices of Special Interest
- Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
National Institute of Allergy and Infectious Diseases
- Notice of Special Interest (NOSI): Improving Outcomes for Disorders of Human Communication
National Institute on Deafness and Other Communication Disorders
- Notice of Special Interest (NOSI): Administrative Supplements to Existing R01 Grants on Polycystic Kidney Disease (PKD)
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Special Interest (NOSI): Development and Preliminary Testing of Health-related Behavioral Interventions
Office of Behavioral and Social Sciences Research
National Center for Complementary and Integrative Health
National Cancer Institute
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Institute of Nursing Research
Funding Opportunities
- Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
National Center for Complementary and Integrative Health
- NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)
National Center for Complementary and Integrative Health
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
National Center for Complementary and Integrative Health
Office of Dietary Supplements
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
National Center for Complementary and Integrative Health
Office of Dietary Supplements
- Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
National Center for Complementary and Integrative Health
- NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
National Institute of Environmental Health Sciences
- Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
- NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
- NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
- NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
Office of Strategic Coordination (Common Fund)
- NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) This FOA solicits applications responsive only to the COVID-19 public health emergency through support of the CARES Act.
Office of Strategic Coordination (Common Fund)
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Carrie Damon at carolyn-damon@uiowa.edu or Dave Myers at dave-myers@uiowa.edu or Lynn Hudachek at lynn-hudachek @uiowa.edu